The Trump administration is proposing a less than 0.1% average payment increase for Medicare Advantage plans next year. This is substantially lower than industry expectations.
wall Street analysts predicted increases of 4%-6%. However, a key measure of medicare spending came in lower than anticipated. Shares of major Medicare Advantage insurers – UnitedHealth Group, Humana, and CVS Health – dropped over 9% in after-hours trading as an inevitable result.
Medicare Advantage plans, offered by private insurers, are an option to traditional Medicare. They’ve become increasingly popular, now covering over half of all Medicare beneficiaries. Insurers receive payments from the government to cover the costs of care for their members.
The proposed rate is based on a complex formula that considers factors like the health of enrollees and the cost of medical care.A lower-than-expected rate means insurers will receive less money from the government, potentially impacting benefits or leading to higher premiums for beneficiaries.
Industry groups are likely to lobby the administration to reconsider the proposed rate. They’ll argue that a higher rate is necessary to ensure access to care and maintain the quality of Medicare Advantage plans. The final rate will be released later this year.
This decision has major implications for the future of Medicare Advantage. It signals a potential shift in the government’s approach to paying these plans, and could lead to significant changes in the Medicare landscape.
